Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

More documents

Recommendations

Info

134Annual Report on Lymphatic Filariasis 20033.2.1 Please list the endemic IUs, with population data, in the table below:Region/provinceTotalName of theendemic IUTotal populationSource ofpopulation dataYear of first roundof MDA3.2.2 Please attach or enclose a map of the country with the updated data of the IUs (showing their statusas endemic (red), non-endemic (green) or uncertain (grey)).ANNEXES Annex 2 Revised Annual Report Form
1353.3 Interruption of transmission3.3.1 Please select the type of MDA chosen (check whichever is applicable).In countries where onchocerciasis is co-endemic:■ Single annual dose mass chemotherapy with ivermectin and albendazoleIn countries where onchocerciasis is not co-endemic:■ Single annual dose mass chemotherapy with DEC and albendazole■ DEC-fortified salt3.3.2 Has any change been made in the IUs targeted for MDA since the last request for drugs was submitted?Yes ■ No ■Annual Report on Lymphatic Filariasis 20033.3.3 If yes, state the reasons why the change was necessary and attach a map of the revised programmearea, providing scale and coordinates.……………………………………………………………………….....................................................................................…………………………….……………………………………………………………………….....................................................................................…………………………….ANNEXES Annex 2 Revised Annual Report Form
Page 1 and 2:
For further information about lymph
Page 3:
WHO/CDS/CPE/CEE/2005.52GlobalProgra
Page 7 and 8:
3Report of the Technical Advisory G
Page 9 and 10:
P R O G R A M M E H I G H L I G H T
Page 11:
I N T R O D U C T I O N7This Annual
Page 14 and 15:
10Annual Report on Lymphatic Filari
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
38Figure 3.2 Outcomes and planning
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 59 and 60:
UNITED REPUBLIC OF TANZANIA55Endemi
Page 61 and 62:
ZANZIBAR, UNITED REPUBLIC OF TANZAN
Page 63:
59AMERICAN PROGRAMME REVIEWGROUPAt
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
82Figure 3.100 Outcomes and plannin
Page 88 and 89: 84Annual Report on Lymphatic Filari
Page 92 and 93: 88Figure 3.118 Outcomes and plannin
Page 94 and 95: 90Figure 3.124 Outcomes and plannin
Page 104 and 105: 100Annual Report on Lymphatic Filar
Page 118 and 119: 114Figure 3.196 Outcomes and planni
Page 127: C H A P T E R 6FURTHER DOCUMENTATIO
Page 135 and 136: ANNUAL REPORT FOR THE NATIONAL PROG
Page 137: 1332. PROGRAMME RESOURCES2.1 Please
Page 141 and 142: 1373.3.6a Report of MDA coverage by
Page 143 and 144: 1393.3.7 Surveys in sentinel sites
Page 145 and 146: 1413.3.10 Please attach a map of th
Page 147 and 148: 1434. SERIOUS ADVERSE EXPERIENCES (
Page 149 and 150: A N N E X E SANNEX 3: LIST OF LF-EN
Page 151 and 152: 147RAPLOARPRGSAESEAROTAG-LFTDRUNDPU
Page 153 and 154: 149Drug administration and monitori
show all

Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

Create successful ePaper yourself

Delete template?

Save as template?